期刊文献+

小鼠淋巴管瘤模型的诱导及其组织病理学观察

Induction of Lymphangiomas in Mice and Histopathological Study
下载PDF
导出
摘要 目的诱导建立小鼠淋巴管内皮细胞肿瘤模型。方法8周龄C57BL/6小鼠16只,腹腔注射弗氏不完全佐剂与PBS(1∶1)乳悬液,间隔15天1次,共注射2次。分4批处死小鼠后,对诱导出的小鼠腹腔新生物进行病理组织学观察,采用免疫组织化学方法检测淋巴管内皮细胞标志性抗原VEGF-C和Flt-4。另以4只小鼠同样方法注射等量PBS液作为对照。结果13只(81.3%)实验小鼠膈肌腹腔面、肝脏表面及侧腹壁腹腔面可见边界清楚的散在分布白色肿瘤样组织,光学显微镜和透射电镜观察发现为由内皮细胞构成的多管腔囊性结构,并表达淋巴管内皮细胞标志性抗原VEGF-C和Flt-4。对照小鼠中未见新生物。结论小鼠腹腔注射弗氏不完全佐剂可稳定诱导小鼠腹腔淋巴管内皮细胞肿瘤模型。 Objective To establish an animal model of benign lymphangiomas in nice.Methods Sixteen C57BL/6 mice accepted twice intraperitoneal injection with incomplete Freund, s adjuvant with 15 days interval. Neoplasms induced were studied histopathologically. The expressions of VEGF-C and Fit-4 were examined by immunohlstochemical method in neoplasms specimen. Results White solid tumor masses were induced in peritoneal cavity in 13 of 16 mice(81.3 % ). The histological study of tumors was lymphangioma,and tumor cells expressed VEGF-C and Fit-4 positively. Conclusion Intraperitoneal injection with incomplete Freund,s adjuvant is a good method to induce benign lymphangiomas in mice.
出处 《实用癌症杂志》 2005年第4期340-342,共3页 The Practical Journal of Cancer
关键词 淋巴管瘤 组织病理学 动物模型 小鼠 Lymphangloma Histopathology Animal model Mice
  • 相关文献

参考文献6

  • 1Wilting J,Neeff H,Christ B.Embryonic lymphangiogene-sis[J].Cell Tissue Res,1999,297(1):1. 被引量:1
  • 2Mancardi S, Stanta G, Dusetti N, et al.Lymphatic endothelial tumors induced by intraperitoneal injection of incomplete Freund's adjuvant[J].Exp Cell Res,1999,246(2):368. 被引量:1
  • 3Karpanen T,Egeblad N,Karkkainen MJ,et al.Vascular endothelia growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth[J].Cancer Res,2001,61(5):1786. 被引量:1
  • 4Peppers MS.Lymphangiogenesisand tumor metastasis:myth or reality[J].Clin Cancer Res,2001,7(3):462. 被引量:1
  • 5Jussila L,Alittalo K.Vascular growth factors and lymphangiogenesis[J].Physiol Rev,2002,82(3):673. 被引量:1
  • 6严超,朱正纲.肿瘤淋巴管生成的研究进展[J].中国癌症杂志,2003,13(5):475-479. 被引量:10

二级参考文献24

  • 1Makinen T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3 [ J]. Nat Med,2001,7 (2) :199-205. 被引量:1
  • 2Ebata N, Nodasaka Y, Sawa Y, et al. Desmoplakin as a specific marker of lymphatic vessels[ J]. Microvas Res,2001,61( 1 ) :40-48. 被引量:1
  • 3Karpanen T, Egeblad M, Karkkainen MJ, et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth[ J ]. Cancer Res ,2001,61 (5) :1786-1790. 被引量:1
  • 4Mattila MMT, Ruohola JK, Katpanen T, et al. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors[J], Int J Cancer, 2002,98(6) : 946-951. 被引量:1
  • 5Yanai Y, Furuhata T, Kimura Y, et al. Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice[ J]. J Exp Clin Cancer Res,2001,20( 3 ) :419-428. 被引量:1
  • 6He Y, Kozaki K, Karpanen T, et al. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling [ J ]. J Natl Cancer Inst,2002, 94( 11 ) : 819-825. 被引量:1
  • 7White JD, Hewett PW, Kosuge D, et al. Vascular endothelial growth factor - D expression is an independent prognostic marker for survival in colorectal carcinoma [ J ]. Cancer Res,2002,62(6) : 1669-1675. 被引量:1
  • 8Hashimoto I, Kodama J, Seki N, et 81. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer[J]. Br J Cancer,2001,85(1): 93-97. 被引量:1
  • 9Ohta Y, Shridhar V, Bright RK, et al. VEGF and VEGF type C play an important role in angiogenesis an lymphangiogeneis in human malignant meaothelioma tumors[J]. Br J Cancer,1999,81(1) : 54-61. 被引量:1
  • 10Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor (VEGFR) -3 in gastric cancer[J]. Eur J Cancer, 2001,37(7) : 918-923. 被引量:1

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部